Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site revision has been updated from v3.5.2 to v3.5.3, indicating a new software release. This backend update does not alter the visible study details content on the page.
    Difference
    0.0%
    Check dated 2026-04-30T17:36:14.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Updated the displayed region name for the Bordeaux site from “Nouvelle-Aquitaine” to “New Aquitaine,” while retaining the same city and postal code.
    Difference
    0.0%
    Check dated 2026-04-23T14:25:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:25:09.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 and removed Padua, Italy, 35128 from the list of study locations.
    Difference
    0.0%
    Check dated 2026-04-09T08:01:08.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added the term Differentiated thyroid carcinoma and a Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:22:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 as a study location and removed Napoli, Italy, 80131. The page revision was updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:31:49.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.